Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data

Abstract Parkinson’s disease (PD) is a complex neurodegenerative disorder with diverse clinical manifestations. To better understand this disease, research has been done to categorize, or subtype, patients, using an array of criteria derived from clinical assessments and biospecimen analyses. In thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew Brendel, Chang Su, Yu Hou, Claire Henchcliffe, Fei Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/937d13cc59a7492c96bf42afe721d192
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:937d13cc59a7492c96bf42afe721d192
record_format dspace
spelling oai:doaj.org-article:937d13cc59a7492c96bf42afe721d1922021-12-02T18:02:07ZComprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data10.1038/s41531-021-00228-02373-8057https://doaj.org/article/937d13cc59a7492c96bf42afe721d1922021-09-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00228-0https://doaj.org/toc/2373-8057Abstract Parkinson’s disease (PD) is a complex neurodegenerative disorder with diverse clinical manifestations. To better understand this disease, research has been done to categorize, or subtype, patients, using an array of criteria derived from clinical assessments and biospecimen analyses. In this study, using data from the BioFIND cohort, we aimed at identifying subtypes of moderate-to-advanced PD via comprehensively considering motor and non-motor manifestations. A total of 103 patients were included for analysis. Through the use of a patient-wise similarity matrix fusion technique and hierarchical agglomerative clustering analysis, three unique subtypes emerged from the clustering results. Subtype I, comprised of 60 patients (~58.3%), was characterized by mild symptoms, both motor and non-motor. Subtype II, comprised of 20 (~19.4%) patients, was characterized by an intermediate severity, with a high tremor score and mild non-motor symptoms. Subtype III, comprised of 23 (~22.3%) patients, was characterized by more severe motor and non-motor symptoms. These subtypes show statistically significant differences when looking at motor (on and off medication) clinical features and non-motor clinical features, while there was no clear difference in demographics, biomarker levels, and genetic risk scores.Matthew BrendelChang SuYu HouClaire HenchcliffeFei WangNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Matthew Brendel
Chang Su
Yu Hou
Claire Henchcliffe
Fei Wang
Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
description Abstract Parkinson’s disease (PD) is a complex neurodegenerative disorder with diverse clinical manifestations. To better understand this disease, research has been done to categorize, or subtype, patients, using an array of criteria derived from clinical assessments and biospecimen analyses. In this study, using data from the BioFIND cohort, we aimed at identifying subtypes of moderate-to-advanced PD via comprehensively considering motor and non-motor manifestations. A total of 103 patients were included for analysis. Through the use of a patient-wise similarity matrix fusion technique and hierarchical agglomerative clustering analysis, three unique subtypes emerged from the clustering results. Subtype I, comprised of 60 patients (~58.3%), was characterized by mild symptoms, both motor and non-motor. Subtype II, comprised of 20 (~19.4%) patients, was characterized by an intermediate severity, with a high tremor score and mild non-motor symptoms. Subtype III, comprised of 23 (~22.3%) patients, was characterized by more severe motor and non-motor symptoms. These subtypes show statistically significant differences when looking at motor (on and off medication) clinical features and non-motor clinical features, while there was no clear difference in demographics, biomarker levels, and genetic risk scores.
format article
author Matthew Brendel
Chang Su
Yu Hou
Claire Henchcliffe
Fei Wang
author_facet Matthew Brendel
Chang Su
Yu Hou
Claire Henchcliffe
Fei Wang
author_sort Matthew Brendel
title Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
title_short Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
title_full Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
title_fullStr Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
title_full_unstemmed Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
title_sort comprehensive subtyping of parkinson’s disease patients with similarity fusion: a case study with biofind data
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/937d13cc59a7492c96bf42afe721d192
work_keys_str_mv AT matthewbrendel comprehensivesubtypingofparkinsonsdiseasepatientswithsimilarityfusionacasestudywithbiofinddata
AT changsu comprehensivesubtypingofparkinsonsdiseasepatientswithsimilarityfusionacasestudywithbiofinddata
AT yuhou comprehensivesubtypingofparkinsonsdiseasepatientswithsimilarityfusionacasestudywithbiofinddata
AT clairehenchcliffe comprehensivesubtypingofparkinsonsdiseasepatientswithsimilarityfusionacasestudywithbiofinddata
AT feiwang comprehensivesubtypingofparkinsonsdiseasepatientswithsimilarityfusionacasestudywithbiofinddata
_version_ 1718378941705617408